05/12/2025
6:06 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:10 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
7:46 PM | Tango Therapeutics (Filer)
| Form DEFR14A | |
04/22/2025
4:14 PM | Tango Therapeutics (Filer)
| Form DEFA14A | |
04/22/2025
4:15 PM | Tango Therapeutics (Filer)
| Form ARS | |
04/21/2025
1:29 PM | Tango Therapeutics (Filer)
| Form DEF 14A | |
04/11/2025
6:11 AM | Tango Therapeutics (Filer)
| Form PRE 14A | |
02/27/2025
6:30 AM | Tango Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:06 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:12 AM | Tango Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
11:33 AM | EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for TNGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/06/2025
7:21 PM | Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:02 PM | Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:08 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
7:10 PM | Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:14 PM | Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:30 PM | Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:31 PM | Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:34 PM | Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:30 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:07 AM | BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/06/2024
10:14 AM | FMR LLC (Filed by)
Tango Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/20/2024
3:24 PM | Tango Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
11/18/2024
6:20 PM | Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
6:24 PM | EcoR1 Capital, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:35 PM | Boxer Capital Management, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
11/07/2024
8:30 PM | Boxer Capital Management, LLC (Reporting)
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
8:40 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
6:43 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:23 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:22 AM | Boxer Capital Management, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/28/2024
5:59 AM | Boxer Capital Management, LLC (Reporting)
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
8:30 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
8:31 PM | Boxer Capital Management, LLC (Reporting)
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:48 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
7:50 PM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
11:03 AM | Boxer Capital Management, LLC (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
8:40 PM | Boxer Capital, LLC (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
10/15/2024
6:25 PM | Boxer Asset Management Inc. (Filed by)
Tango Therapeutics (Subject)
| Form SC 13D/A | |
09/17/2024
3:48 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:43 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
09/09/2024
6:19 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
8:01 PM | Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:45 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Filed by)
| Form SC 13D/A | |
08/30/2024
4:24 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:40 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:53 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:59 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:35 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
4:14 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
6:07 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:13 AM | Tango Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
4:51 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:32 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:15 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
4:41 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
4:48 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:58 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:39 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
3:15 PM | Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
4:30 PM | Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
7:56 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:14 PM | Davis Aaron I. (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:17 PM | Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:21 PM | Peters Malte (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:11 PM | Borisy Alexis (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:13 PM | Ketchum John B (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:16 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:27 PM | Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
6:18 AM | Tango Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
